Side effects of novel PI3K inhibitors
A novel BTK inhibitor BGB-3111: new data presented at ASH 2017
How can we overcome ibrutinib resistance?
Overview of novel restore and target treatment approach to classical Hodgkin lymphoma
A novel WINDOW of opportunity for young mantle cell lymphoma patients